Abbott's (ABT) Q4 Earnings Match Estimates, Margins Rise

Abbott Laboratories (ABT) reported fourth-quarter 2023 adjusted earnings per share (EPS) of $1.19, in line with the Zacks Consensus Estimate. The adjusted figure increased 15.5% from the prior-year quarter’s level. The quarter’s adjustments include 28 cents of certain non-recurring items.GAAP EPS came in at 91 cents, which increased 54.2% year over year.Full-year adjusted EPS was$ 4.44, reflecting a 16.9% decline from the 2022 figure. The figure, too, however, came in line with the Zacks Consensus Estimate. ...